Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study

Abstract Background In critically ill patients, drug incompatibilities frequently occur because of the number of drugs to be administered through a limited number of infusion lines. These are among the main causes of particulate contamination. However, little data is available to quantify particle e...

Full description

Bibliographic Details
Main Authors: Malik Benlabed, Anthony Martin Mena, Romain Gaudy, Maxime Perez, Stéphanie Genay, Jean-Daniel Hecq, Pascal Odou, Gilles Lebuffe, Bertrand Décaudin
Format: Article
Language:English
Published: SpringerOpen 2018-10-01
Series:Intensive Care Medicine Experimental
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40635-018-0205-2
id doaj-0981219dbabf414f875db87848fe4b38
record_format Article
spelling doaj-0981219dbabf414f875db87848fe4b382020-11-25T01:18:34ZengSpringerOpenIntensive Care Medicine Experimental2197-425X2018-10-01611910.1186/s40635-018-0205-2Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro studyMalik Benlabed0Anthony Martin Mena1Romain Gaudy2Maxime Perez3Stéphanie Genay4Jean-Daniel Hecq5Pascal Odou6Gilles Lebuffe7Bertrand Décaudin8Univ. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesUniv. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesUniv. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesUniv. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesUniv. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesDepartment of Pharmacy, CHU UCL NamurUniv. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesUniv. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesUniv. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesAbstract Background In critically ill patients, drug incompatibilities frequently occur because of the number of drugs to be administered through a limited number of infusion lines. These are among the main causes of particulate contamination. However, little data is available to quantify particle exposure during simultaneous IV-drug infusion. The objective of this study was to evaluate the particulate matter potentially administered to critically ill patients. Methods The particulate matter (between 1 μm and 30 mm) of infused therapies used in ICUs for patients suffering from either septic shock or acute respiratory distress syndrome was measured in vitro over 6 h using a dynamic image analysis device, so that both overall particulate contamination and particle sizes could be determined. Data is presented according to the recommendations of the European Pharmacopoeia (≥ 10 and 25 μm). Results For the six experimental procedures (continuous infusion of norepinephrine, midazolam, sufentanil, heparin, 5% glucose, binary parenteral nutrition and discontinuous administrations of omeprazole, piperacillin/tazobactam and fluconazole), the overall number of particles over the 6-h infusion period was 8256 [5013; 15,044]. The collected values for the number of particles ≥ 10 and 25 μm were 281 [118; 526] and 19 [7; 96] respectively. Our results showed that discontinuous administrations of drugs led to disturbances in particulate contamination. Conclusions This work indicates the amount of particulate matter potentially administered to critically ill adult patients. Particulate contamination appears lower than previous measurements performed during multidrug IV therapies in children.http://link.springer.com/article/10.1186/s40635-018-0205-2Parenteral nutritionIntravenousInfusion pumpsDrug incompatibilityCritical care
collection DOAJ
language English
format Article
sources DOAJ
author Malik Benlabed
Anthony Martin Mena
Romain Gaudy
Maxime Perez
Stéphanie Genay
Jean-Daniel Hecq
Pascal Odou
Gilles Lebuffe
Bertrand Décaudin
spellingShingle Malik Benlabed
Anthony Martin Mena
Romain Gaudy
Maxime Perez
Stéphanie Genay
Jean-Daniel Hecq
Pascal Odou
Gilles Lebuffe
Bertrand Décaudin
Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study
Intensive Care Medicine Experimental
Parenteral nutrition
Intravenous
Infusion pumps
Drug incompatibility
Critical care
author_facet Malik Benlabed
Anthony Martin Mena
Romain Gaudy
Maxime Perez
Stéphanie Genay
Jean-Daniel Hecq
Pascal Odou
Gilles Lebuffe
Bertrand Décaudin
author_sort Malik Benlabed
title Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study
title_short Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study
title_full Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study
title_fullStr Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study
title_full_unstemmed Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study
title_sort analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study
publisher SpringerOpen
series Intensive Care Medicine Experimental
issn 2197-425X
publishDate 2018-10-01
description Abstract Background In critically ill patients, drug incompatibilities frequently occur because of the number of drugs to be administered through a limited number of infusion lines. These are among the main causes of particulate contamination. However, little data is available to quantify particle exposure during simultaneous IV-drug infusion. The objective of this study was to evaluate the particulate matter potentially administered to critically ill patients. Methods The particulate matter (between 1 μm and 30 mm) of infused therapies used in ICUs for patients suffering from either septic shock or acute respiratory distress syndrome was measured in vitro over 6 h using a dynamic image analysis device, so that both overall particulate contamination and particle sizes could be determined. Data is presented according to the recommendations of the European Pharmacopoeia (≥ 10 and 25 μm). Results For the six experimental procedures (continuous infusion of norepinephrine, midazolam, sufentanil, heparin, 5% glucose, binary parenteral nutrition and discontinuous administrations of omeprazole, piperacillin/tazobactam and fluconazole), the overall number of particles over the 6-h infusion period was 8256 [5013; 15,044]. The collected values for the number of particles ≥ 10 and 25 μm were 281 [118; 526] and 19 [7; 96] respectively. Our results showed that discontinuous administrations of drugs led to disturbances in particulate contamination. Conclusions This work indicates the amount of particulate matter potentially administered to critically ill adult patients. Particulate contamination appears lower than previous measurements performed during multidrug IV therapies in children.
topic Parenteral nutrition
Intravenous
Infusion pumps
Drug incompatibility
Critical care
url http://link.springer.com/article/10.1186/s40635-018-0205-2
work_keys_str_mv AT malikbenlabed analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy
AT anthonymartinmena analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy
AT romaingaudy analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy
AT maximeperez analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy
AT stephaniegenay analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy
AT jeandanielhecq analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy
AT pascalodou analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy
AT gilleslebuffe analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy
AT bertranddecaudin analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy
_version_ 1725141860502994944